Haemonetics(R) Announces Expanded Roles for Executive Management

BRAINTREE, Mass., Aug. 8 /PRNewswire-FirstCall/ -- The Company announced today approval by the Board of Directors of expanded roles for several executives as part of the Company's succession and development plan that helps achieve the Company's long term vision as global leader of blood solutions, and execute on the Company's strategies to grow shareholder value.

Chris Lindop, Chief Financial Officer and VP Business Development, who joined the Company earlier this year, will also take on the responsibility for Investor Relations as well as the Company's Arryx business. The Company purchased Arryx last year to develop its holographic optical trapping nano technology, beginning with a blood typing product. Prior to Haemonetics, Mr. Lindop had been Chief Financial Officer of Inverness, a company with a full portfolio of IVD (In Vitro Diagnostics) products.

Brian Concannon, who joined the Company in 2004, is appointed to the new position of Chief Operating Officer. In this expanded role, Mr. Concannon will have overall accountability for global sales and marketing across the Company's entire product portfolio and geographies.

Lisa Lopez, who joined the Company in 1988, is appointed to the new position of Vice President Corporate Affairs, which will include Legal & External Affairs, Medical, Regulatory & Clinical Affairs, Corporate Ethics, and Internal Audit.

Jim O'Shaughnessy, who joined the Company in 2004 as Deputy General Counsel, is promoted to General Counsel reporting to Ms. Lopez.

Brad Nutter, President and Chief Executive Officer, said, "Haemonetics has the strongest management team in its history. These changes continue to broaden and deepen our management bench strength, and are aligned with our vision, strategic initiatives and long term succession plan to grow the business."

Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collection, plasma collection, and blood component safety. To learn more about Haemonetics' products and markets, visit its web site at http://www.haemonetics.com/.

Contact: Denise McEvily Tel. (781) 356-9457 Alternate Tel: (508) 380-4085 dmcevily@haemonetics.com